Mobile Health + Mindfulness for Breast Cancer Survivors
(F2TMind Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, it mentions that participants may still be undergoing endocrine or hormone therapies, suggesting that some medications might be allowed.
What data supports the effectiveness of the treatment Mobile Health + Mindfulness for Breast Cancer Survivors?
Is mindfulness-based therapy safe for breast cancer survivors?
How is the Mobile Health + Mindfulness treatment for breast cancer survivors different from other treatments?
What is the purpose of this trial?
The primary purpose of the present study is to apply MOST methodology to determine which types of social support and mindfulness training intervention components optimally increase MVPA adoption and maintenance in Breast Cancer Survivors (BCS) in a 24-week intervention with a 48-week follow-up. The researchers will also examine the effects of changes in MVPA on symptom burden, time spent in intensities of other activities (i.e. light and sedentary), and sleep quality and duration.Aim 1: To identify which components from four mHealth components under consideration for inclusion meaningfully contribute to improvements in MVPA at 24 and 48 weeks.Aim 2: To examine how changes in MVPA, as a result of the 4 components, may influence additional health behaviors and outcomes including: a) symptom burden (i.e. fatigue, depression, anxiety); b) time spent i n other activity intensities (i.e. light, sedentary time); and c) sleep duration and quality.Aim 3: To examine potential mediators (i.e. adherence, psychosocial factors such as post-traumatic growth, self-compassion, self-efficacy, and goal-setting) and moderators (i.e., age, time since diagnosis) of the four intervention components on MVPA.
Research Team
Siobhan M Phillips, PhD, MPH
Principal Investigator
Northwestern University
David E Victorson, PhD
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for female breast cancer survivors, aged 18 or older, with a Stage I-III diagnosis in the past 5 years and less than 60 minutes of moderate to vigorous physical activity per week. They must have internet access, a smartphone, speak English fluently, and be post-primary treatment. Buddies supporting them should also meet similar criteria.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline assessments and are randomized into intervention groups
Intervention
Participants engage in a 24-week intervention involving mHealth components to increase MVPA
Follow-up
Participants maintain MVPA and are monitored for outcomes without direct contact from the study team
Treatment Details
Interventions
- General Mindfulness Training
- MVPA-Specific Mindfulness Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator